130 related articles for article (PubMed ID: 33032945)
1. Prevalence and predictors of patients reporting adverse drug reactions to health care providers during oral targeted cancer treatment.
Monestime S; Page R; Jordan WM; Aryal S
J Am Pharm Assoc (2003); 2021; 61(1):53-59. PubMed ID: 33032945
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
3. Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.
Thomas PWA; Römkens TEH; West RL; Russel MGVM; Jansen JM; van Lint JA; Jessurun NT; Hoentjen F
United European Gastroenterol J; 2021 Oct; 9(8):919-928. PubMed ID: 34077634
[TBL] [Abstract][Full Text] [Related]
4. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
5. The value of patient reporting to the pharmacovigilance system: a systematic review.
Inácio P; Cavaco A; Airaksinen M
Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
[TBL] [Abstract][Full Text] [Related]
6. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
Adisa R; Adeniyi OR; Fakeye TO
Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
[TBL] [Abstract][Full Text] [Related]
8. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
9. Common causes and characteristics of adverse drug reactions in older adults: a retrospective study.
Woo SD; Yoon J; Doo GE; Park Y; Lee Y; Lee SH; Lee YH; Ye YM
BMC Pharmacol Toxicol; 2020 Dec; 21(1):87. PubMed ID: 33303036
[TBL] [Abstract][Full Text] [Related]
10. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
11. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance.
Fornasier G; Taborelli M; Francescon S; Polesel J; Aliberti M; De Paoli P; Baldo P
Int J Clin Pharm; 2018 Aug; 40(4):795-802. PubMed ID: 29785683
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
14. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
Hariraj V; Aziz Z
Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
[TBL] [Abstract][Full Text] [Related]
15. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
[TBL] [Abstract][Full Text] [Related]
16. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals.
Harugeri A; Parthasarathi G; Ramesh M; Guido S; Basavanagowdappa H
J Postgrad Med; 2011; 57(3):189-95. PubMed ID: 21941055
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reactions experience in a teaching hospital in Jordan.
Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
[TBL] [Abstract][Full Text] [Related]
18. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
19. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
[TBL] [Abstract][Full Text] [Related]
20. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Matos C; van Hunsel F; Joaquim J
Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
